View of Valences of consumer protection in the perimeter of effectiveness associated with pharmaceutical products: comment on the decisions of the C.J.E.U. in joined cases C‑495/21, C‑496/21 and in case C-616/20 | Studia Universitatis Babeș-Bolyai Iurisprudentia